Zobrazeno 1 - 10
of 148
pro vyhledávání: '"H.E. Harrison"'
Autor:
R.E. Webber, H.D. Symonds, W.C. Unwin, A.P. Trotter, J.D. Cormack, R.T. Glazebrook, H.E. Harrison, C.A. Buckmaster, J.A. Flemming, W.J. Lineham, R.H. Smith, Magnus MaClean, H. Hirst, E. Kilburn Scott, T.A. Locke, E.S.A. Robson, O.I. Davis, W.J. Williams, null Walmsley
Publikováno v:
Journal of the Institution of Electrical Engineers. 33:423-470
Autor:
Willoughby Smith, Alexander Simens, W.E. Ayrton, J. Hopkinson, Edward Hopkinson, H.E. Harrison, Silvanus P. Thompson
Publikováno v:
Journal of the Society of Telegraph-Engineers and Electricians. 13:524-540
Autor:
E.L. Nichols, R.T. Glazebrook, A.G. Webster, H.S. Carhart, H.E. Harrison, A.K. Kennelly, J. Perry, F.A. Wolff, C.H. Sharp, G.W. Patterson, W. Duddell, A.E. Kennelly, K.E. Guthe
Publikováno v:
Journal of the Institution of Electrical Engineers. 34:208-228
Autor:
C.E. Spagnoletti, M. Hospitalier, null Forbes, J. Munro, null Ayrton, null Biggs, null Fleming, J.B. Bright, null Shoolbred, H.E. Harrison, null Swinburne, null Walmsley, null Hughes, null Jamieson
Publikováno v:
Journal of the Society of Telegraph-Engineers and Electricians. 14:311-333
Autor:
F. Bailey, W.M. Mordey, Silvanus P. Thomson, J. Swinburne, W.E. Sumpner, R.E.B. Crompton, G. Kapp, Leslie Miller, R.W. Weekes, John Hopkinson, H.E. Harrison, J.A. Fleming
Publikováno v:
Journal of the Institution of Electrical Engineers. 22:164-194
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Thrombosis and Haemostasis.
Many abnormalities of platelet function occur in patients with diabetes mellitus, partioularly those with angiopathy. We have previously demonstrated that prostacyclin (PGI2) is decreased in streptozotocin-diabetic rats, and have now investigated pla
Publikováno v:
Lancet (London, England). 1(8111)
Publikováno v:
Metabolism: clinical and experimental. 34(4)
ICI 128,436 (3-(4-bromo-2-fluorobenzyl)-4-oxo-3H-phthalazin-1-ylacetic acid) is a chemically novel, potent inhibitor of aldose reductase. It inhibits partially purified aldose reductase isolated from a number of sources including human tissue (human
Publikováno v:
The Lancet. 332:1305